SCHEMBL16410669

SCHEMBL16410669

N=Cc1cccc(CNNC2=Nc3cc(Cl)c(Cl)cc3NC23CCCCC3)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410618 0.87 KDM4E (0.31) —
SCHEMBL16410792 0.86 KMT2A (0.38) —
SCHEMBL16410758 0.80 KMT2A (0.36) —
SCHEMBL16410775 0.78 — —
SCHEMBL16410858 0.78 PIK3CA (0.35) —
SCHEMBL16410782 0.78 ACAT2 (0.34) —
SCHEMBL17757642 0.77 MAOB (0.36) —
SCHEMBL17757436 0.77 MAOB (0.36) —
SCHEMBL16410700 0.77 ACAT2 (0.38) —
SCHEMBL16410559 0.77 NOS3 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback